Health
PharmAust’s MPL and MPLS drug candidates again indicate antiviral activity in SARS-CoV2 – Small Caps
Further pre-clinical testing of PharmAust’s (ASX: PAA) monepantel (MPL) and monepantel sulphone (MPLS) drugs continues to demonstrate antiviral activity in cultured…
Further pre-clinical testing of PharmAusts (ASX: PAA) monepantel (MPL) and monepantel sulphone (MPLS) drugs continues to demonstrate antiviral activity in cultured cell infection models of SARS-CoV2 the virus causing the global COVID-19 pandemic.
Following positive earlier results in both primate and non-primate cell cultures, Leiden University Medical Centre has carried out more tests and generated data indicating both MPL and MPLS demonstrate antiviral activity in non-human primates.
This paves…
-
Noosa News21 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News20 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
Noosa News19 hours agoMissing man, Maroochydore – Queensland Police News
-
General22 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out